Biotech company, Biogen Inc.’s (BIIB - Free Report) shares were up more than 5% in pre-market trading with the company surpassing earnings expectations by a wide margin. Revenues also surpassed expectations. The company reported …
ZACKS11mon
I have been patiently waiting for a bull market to begin in Biogen Inc (NASDAQ:BIIB) stock. I got my hopes up after the United States presidential election results revealed that Donald Trump was the victor, and BIIB stock—and the entire …
They set a "buy" rating and a $345.00 target price on the stock. About 1.74 million shares traded. Biotest AG (ETR:BIO) has risen 53.78% since June 2, 2016 and is uptrending. It has underperformed by 36.27% the S&P500. Biogen Inc …
"Clearly, to this point the Goldilocks scenario and earnings have pushed stock prices higher but oil has perhaps tempered some sentiment near-term", said Terry …
Biogen stock is getting whacked in sympathy to Eli Lilly's announcement that it has once again failed in its quest to prove solanezumab to be a viable treatment for Alzheimer's patients. While trading in sympathy is common on Wall Street, it …
The share price of Biogen Inc. (NASDAQ:BIIB) tumbled as much as 8 percent, to $395, Friday after sales of the …
InvestorPlace - Stock Market News, Stock Advice & Trading TipsBiogen (BIIB) stock was up on Tuesday following positive news included in its earnings report for the first quarter of 2017.The post Biogen Inc (BIIB) Stock Pops on Strong Q1 …
Fundamentally speaking, many biotech stocks have continued to increase their …
Alexion’s stock has increased by more than 22% percent [20 points] since …